DDW seminar on AI and automation at ELRIG Drug Discovery 2022 

Supported by DDW, the Tech Theatre at ELRIG Drug Discovery 2022 will feature a series of seminars focused on automation and technology for drug discovery. 

Dr Yahya Anvar, Head of Data Science Okra.AI will be discussing The Role of AI and Automation in Personalised Medicine: How can AI Help in The Post Drug Discovery Process.   

Dr Yahya Anvar, Head of Data Science Okra.AI

Dr Anvar was a senior scientist before joining OKRA, serving as the principal investigator of preclinical personalised medicine. He has over 12 years of experience in the healthcare sector and is the author of over 30 peer-reviewed scientific articles. Dr Anvar holds a PhD in Medicine from Leiden University, and an MSc in Bioinformatics and Artificial Intelligence from Brunel University.  

The event will take place on 4-5 Oct, London Excel, UK and additional topics will include: 

  • First steps into automation: The challenges – financial, skills, objections – and how to overcome them 
  • The lab of the future is now: Automating the discovery process for every budget 
  • Data handling and choosing the right informatics systems for your lab requirements 
  • The sustainable lab. What are the business drivers to sustainability 
  • The automated lab and the human 
  • The remote lab: is this the future? 
  • How can automation push the development of biologics and biosimilars? 

Seminars are free to attend but spaces are limited and require advanced registration. Click herenow to register. 

 

 

 

 

Suggested Reading

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free